Oruka Therapeutics, Inc.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Mar 2022 | — | $47.9M | $49.1M |
| Jun 2022 | — | $45.0M | $46.4M |
| Sep 2022 | — | $42.7M | $43.9M |
| Dec 2022 | — | $41.7M | $42.4M |
| Mar 2023 | — | $40.5M | $40.9M |
| Jun 2023 | — | $39.2M | $40.2M |
| Sep 2023 | — | $38.0M | $38.5M |
| Dec 2023 | — | $37.0M | $37.4M |
| Feb 2024 | — | $1.0K | — |
| Feb 2024 | — | $1.0K | — |
| Mar 2024 | — | $-7.1M | $35.9M |
| Jun 2024 | — | $-29.0M | $33.3M |
| Sep 2024 | — | $342.4M | $410.9M |
| Dec 2024 | — | $382.2M | $61.6M |
| Mar 2025 | — | $364.7M | $83.6M |
| Jun 2025 | — | $343.6M | $65.4M |
| Sep 2025 | — | $486.8M | $91.3M |
| Dec 2025 | — | $471.9M | $46.9M |
| Mar 2026 | — | $486.7M | $49.5M |
| Jun 2026 | — | $1.11B | $268.5M |